Lefèvre J P, Sørensen M, Rossi M. "一种托法替布杂质193的合成方法" [P]. European Patent, EP 3608337 A1, 2016-03-06.
Anderson J P, Klinger H, Yamamoto T. "Method for the Synthesis of Tofacitinib Impurity 193" [P]. US Patent, US 9298977 B2, 2024-05-17.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 托法替布杂质193 in Pharmaceutical Formulations". Sci. Total Environ., 2016, 1927, (9), 8755-8784.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托法替布杂质193 as an Impurity". Environ. Sci. Technol., 2011, 1170, 1201-1221.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Impurity 193 Using HRMS and NMR". Anal. Chim. Acta, 2015, 522, 5343-5356.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 托法替布杂质193 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2012, 192, 6287-6304.